Pregnancy-Related Changes of Amino Acid and Acylcarnitine Concentrations: The Impact of Obesity

Abstract

Objective Our primary objective was to assess the difference in amino and fatty acid biomarkers throughout pregnancy in women with and without obesity. Interactions between biomarkers and obesity status for associations with maternal and fetal metabolic measures were secondarily analyzed.

Methods Overall 39 women (15 cases, 24 controls) were enrolled in this study during their 15- to 20-weeks' visit at the University of Iowa Hospitals and Clinics. We analyzed 32 amino acid and acylcarnitine concentrations with tandem mass spectrometry for differences throughout pregnancy as well as among women with and without obesity (body mass index [BMI] ≥ 35, BMI < 25).

Results There were substantial changes in amino acids and acylcarnitine metabolites between the second and third trimesters (nonfasting state) of pregnancy that were significant after correcting for multiple testing (p < 0.002). Examining differences by maternal obesity, C8:1 (second trimester) and C2, C4-OH, C18:1 (third trimester) were higher in women with obesity compared with women without obesity. Several metabolites were marginally (0.002 < p < 0.05) correlated with birth weight, maternal glucose, and maternal weight gain stratified by obesity status and trimester.

Conclusions Understanding maternal metabolism throughout pregnancy and the influence of obesity is a critical step in identifying potential mechanisms that may contribute to adverse outcomes in pregnancies complicated by obesity.

Keywords

acylcarnitines - fatty acids - amino acids - maternal obesity - pregnancy - longitudinal

• References

• 1 Obesity and Overweight. Geneva, Switzerland. World Health Organization. https://www.who.int/mediacentre/factsheets/fs311/en/ . Accessed 2015
• 2 Oberbach A, Blüher M, Wirth H , et al. Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J Proteome Res 2011; 10 (10) 4769-4788
• 3 Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444 (7121) 875-880
• 4 Park S, Sadanala KC, Kim EK. A Metabolomic Approach to Understanding the Metabolic Link between Obesity and Diabetes. Mol Cells 2015; 38 (7) 587-596
• 5 He Q, Ren P, Kong X , et al. Comparison of serum metabolite compositions between obese and lean growing pigs using an NMR-based metabonomic approach. J Nutr Biochem 2012; 23 (2) 133-139
• 6 Williams R, Lenz EM, Wilson AJ , et al. A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats. Mol Biosyst 2006; 2 (3–4) 174-183
• 7 Newgard CB, An J, Bain JR , et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009; 9 (4) 311-326
• 8 Hadden DR, McLaughlin C. Normal and abnormal maternal metabolism during pregnancy. Semin Fetal Neonatal Med 2009; 14 (2) 66-71
• 9 Centers for Disease Control and Prevention: About adult BMI. In: Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion. https://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/ . Accessed 2015
• 10 Mei JV, Alexander JR, Adam BW, Hannon WH. Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr 2001; 131 (5) 1631S-1636S
• 11 Ryckman KK, Berberich SL, Shchelochkov OA, Cook DE, Murray JC. Clinical and environmental influences on metabolic biomarkers collected for newborn screening. Clin Biochem 2013; 46 (1–2) 133-138
• 12 Metzger BE, Unger RH, Freinkel N. Carbohydrate metabolism in pregnancy. XIV. Relationships between circulating glucagon, insulin, glucose and amino acids in response to a “mixed meal” in late pregnancy. Metabolism 1977; 26 (2) 151-156
• 13 Thompson DK, Sloane R, Bain JR , et al. Daily Variation of Serum Acylcarnitines and Amino Acids. Metabolomics 2012; 8 (4) 556-565
• 14 Endo S, Maeda K, Suto M , et al. Differences in insulin sensitivity in pregnant women with overweight and gestational diabetes mellitus. Gynecol Endocrinol 2006; 22 (6) 343-349
• 15 Nelson SM, Matthews P, Poston L. Maternal metabolism and obesity: modifiable determinants of pregnancy outcome. Hum Reprod Update 2010; 16 (3) 255-275
• 16 Vidakovic AJ, Jaddoe VW, Gishti O , et al. Body mass index, gestational weight gain and fatty acid concentrations during pregnancy: the Generation R Study. Eur J Epidemiol 2015; 30 (11) 1175-1185
• 17 Tomedi LE, Chang CC, Newby PK , et al. Pre-pregnancy obesity and maternal nutritional biomarker status during pregnancy: a factor analysis. Public Health Nutr 2013; 16 (8) 1414-1418
• 18 Al MD, van Houwelingen AC, Badart-Smook A, Hasaart TH, Roumen FJ, Hornstra G. The essential fatty acid status of mother and child in pregnancy-induced hypertension: a prospective longitudinal study. Am J Obstet Gynecol 1995; 172 (5) 1605-1614
• 19 Al MD, van Houwelingen AC, Hornstra G. Long-chain polyunsaturated fatty acids, pregnancy, and pregnancy outcome. Am J Clin Nutr 2000; 71 (1, Suppl) 285S-291S
• 20 Miller AL. The methionine-homocysteine cycle and its effects on cognitive diseases. Altern Med Rev 2003; 8 (1) 7-19
• 21 Mascarenhas M, Habeebullah S, Sridhar MG. Revisiting the role of first trimester homocysteine as an index of maternal and fetal outcome. J Pregnancy 2014; 2014: 123024
• 22 Refsum H, Nurk E, Smith AD , et al. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr 2006; 136 (6, Suppl) 1731S-1740S
• 23 Murphy MM, Scott JM, Arija V, Molloy AM, Fernandez-Ballart JD. Maternal homocysteine before conception and throughout pregnancy predicts fetal homocysteine and birth weight. Clin Chem 2004; 50 (8) 1406-1412
• 24 Fryer AA, Emes RD, Ismail KM , et al. Quantitative, high-resolution epigenetic profiling of CpG loci identifies associations with cord blood plasma homocysteine and birth weight in humans. Epigenetics 2011; 6 (1) 86-94